US firm Brownstein nabs five from Crowell ‘at pivotal moment’

Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Careers

King & Spalding continues hiring spree from pre-merged Winston

30 June 2026 The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from Winston & Strawn before its merger.

Careers

Ashurst Perkins Coie opens its doors following landmark merger

29 June 2026 The newly combined transatlantic firm brings together more than 950 partners across 20 countries, uniting leading patent, trade secrets, life sciences, and tech practices.

Careers

Cooley Asia transactions duo make rival firm move

23 June 2026 The pair bring a strong track record advising life sciences companies on licensing, collaboration and commercialisation agreements, with a particular focus on cross-border biotech transactions.

More features

Will Mounjaro and Zepbound get their first US generic rival?

King & Spalding continues hiring spree from pre-merged Winston

Ashurst Perkins Coie opens its doors following landmark merger

Merck KGaA agrees $11.3bn deal in major life sciences expansion

Pfizer’s US Paxlovid patent fight turns on a single error

Novartis and Eli Lilly sign separate $1.9bn novel drug deals

Novo secures website blocking to tackle fake weight-loss drugs

GLP-1 patents and Africa: The COVID-19 lessons we still have not learned

US firm Brownstein nabs five from Crowell ‘at pivotal moment’

More on this story

Editor's picks

Editor's picks

More features